Damon Wayans details his type 2 diabetes journey, the symptoms that alarmed him and his new partnership to raise awareness ...

Just a few years ago, Daniel Chen, M.D., Ph.D., was spending his spare time in his backyard, sketching out designs for new ...

When Glenn Carroll talks to managers about the culture at their organization, about 80% of them say it needs to change. Yet ...

Oculomics, the study of eye biomarkers of systemic disease, is gaining traction as retinal imaging and AI advance. Tear ...

Roche Group's Genentech said its Enspryng drug lowered the risk of relapse for patients with a type of autoimmune disorder in a Phase 3 study, meeting the study's primary endpoint.

Gap widens between Wall Street and consumers, companies apply for tariff refunds, is AI really responsible for job cuts?

Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to teriflunomide in reducing relapses and brain lesions in relapsing multiple ...

Amazon Web Services (AMZN) offers businesses and professionals a growing variety of platforms to train and develop AI models.

From probiotics to do-it-yourself IgG test kits, social media is misinforming patients about how to diagnose and manage ...

After taking on pharmacies with his discount-drug startup, the billionaire is taking on health insurers with a skunkworks ...

While President Donald Trump has repeatedly said the prices of prescription drugs would be lowered under deals with ...

Last month marked Women’s History Month, and in February there was International Day of Women and Girls in Science, too. But, ...